Teva Pharmaceutical Industries Issues Public Comment on FDA Notice
2020-05-22
zz-Public Comments2020-05-22
Targeted News Service
WASHINGTON, May 22 -- Scott D. Tomsky, vice president for generics regulatory affairs North America at Teva Pharmaceutical Industries Ltd., Parsippany, New Jersey, has issued a public comment on the F . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
WASHINGTON, May 22 -- Scott D. Tomsky, vice president for generics regulatory affairs North America at Teva Pharmaceutical Industries Ltd., Parsippany, New Jersey, has issued a public comment on the F . . .
TARGETED NEWS SERVICE (founded 2004) features non-partisan 'edited journalism' news briefs and information for news organizations, public policy groups and other organizations. For more information contact MYRON STRUCK, editor, editor@targetednews.com, Springfield, Virginia; 703/304-1897; https://targetednews.com
Copyright © Targeted News Service, 2020